Vankadari Aditya

Dr. Vankadari Aditya

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
BDBarani Thillai Devi
Barani Thillai Devi
VAVankadari Aditya
Vankadari Aditya
SKSudarshan Kini
Sudarshan Kini
BKBallamoole Krishna Kumar
Ballamoole Krishna Kumar
VDVK Deekshit
VK Deekshit
Aim: The increasing prevalence of multidrug-resistant Escherichia coli and Klebsiella pneumoniae presents a critical threat to public health. As a first line of defence, efflux pumps promote antibiotic resistance among pathogens. This study aims to assess the potential of efflux pump inhibitors (EPIs) as adjuvants for enhancing antibiotic efficacy against resistant pathogens. Methods and results: This research investigated antibiotic resistance patterns, antibiotic resistance genes, and the effects and expression profiles of efflux pump genes. The study examined bacterial responses to sub-inhibitory levels of antibiotics, both individually and in conjunction with the EPI. The real-time PCR/Quantitative PCR (qPCR) demonstrated that antibiotic exposure led to an upregulation of efflux genes in E. coli and K. pneumoniae, with significant strain-specific differences. The co-administration of EPI resulted in downregulation of efflux genes, indicating successful inhibition of the pumps. Gene expression analyses suggested that PAβN influences the regulation of efflux genes and may trigger oxidative stress responses mediated by global regulators. This implies that EPIs could directly and indirectly affect bacterial physiology. Conclusions: The results highlight the therapeutic promise of EPIs in combating antibiotic resistance. This study underscores the complexity of efflux-mediated resistance and the need for integrated strategies to mitigate MDR in Gram-negative pathogens.

9 August 2021 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
VAVankadari Aditya
Vankadari Aditya
AKAkshatha Kotian
Akshatha Kotian
SSSreya Saikrishnan
Sreya Saikrishnan
AKAnusha Karunasagar
Anusha Karunasagar
DMDivyashree Mithoor
Divyashree Mithoor
VDVK Deekshit
VK Deekshit
Aim This study aimed at characterizing the biofilm-forming ability of drug-resistant and sensitive Escherichia coli under in vitro gut conditions and in the presence of ciprofloxacin. Methods and Results 153 E. coli isolates comprising 80 from clinical and 73 from environment source were studied for their ability to form biofilm under control and in vitro simulated gut conditions. The integrity of preformed biofilm on exposure to ciprofloxacin was assessed. Expression of biofilm-associated genes was analysed using qPCR. A high degree of resistance was observed in clinical isolates with a concomitant prevalence of blaTEM. Bile, pH and low temperature enabled the E. coli biofilm to resist the effect of ciprofloxacin. Clinical isolates of E. coli formed strong biofilms in in vitro gut conditions following exposure to high concentration of ciprofloxacin. The expression of biofilm genes varied between different gut conditions viz., presence of bile, pH and low temperature, included in this study. Conclusions This study demonstrates the importance of papC and csgA for maintaining the biofilm integrity upon antibiotic exposure. Escherichia coli form biofilm as a survival strategy to adapt to the conditions in their environment irrespective of their drug resistance status. Significance and Impact of the Study The study provides an understanding of the effect of different parameters of the gut conditions during infection and the effect of antibiotic on survival and biofilm-forming ability of clinical and environmental E. coli isolates. It further suggests that bacteria resort to biofilm formation as one of the mechanisms to adjust to alterations in gut conditions and once the biofilm is formed, it requires high concentration of ciprofloxacin to eradicate it.

15 July 2025 in Acta Tropica
Verified
Journal Article
Open access
DBDivya Bhat
Divya Bhat
ARAsha K Rajan
Asha K Rajan
VAVankadari Aditya
Vankadari Aditya
VEVandana Kalwaje Eshwara
Vandana Kalwaje Eshwara
MVMuralidhar Varma
Muralidhar Varma
VSVishal Shanbhag
Vishal Shanbhag
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a critical pathogen associated with high mortality in bloodstream infections, particularly in regions with high antimicrobial resistance. Aim of this study was to identify antimicrobial resistance patterns, clinical outcomes, and independent risk factors for mortality among patients with K. pneumoniae bacteraemia (KPB), comparing CRKP and carbapenem sensitive K. pneumoniae (CSKP) infections. A retrospective observational study was conducted among adult ICU patients diagnosed with KPB between January to December 2023. Demographics, comorbidities, laboratory markers, treatment details, and clinical outcomes were matched between CRKP and CSKP groups. Univariate and multivariate logistic regression were used to identify independent predictors of mortality. Kaplan-Meier analysis was used to assess survival differences. All the analyses were performed using SPSS vs 20.0 software. Among 116 patients, 55.2 % had CRKP bacteraemia. CRKP patients had old age (>65 years) and had higher rates of comorbidities including chronic liver (26.5 %) and kidney disease (15.6 %). Overall mortality rate was higher in CRKP patients (57.8 %). Seven factors were independently associated with mortality: old age [OR:1.402(1.097-2.005)], chronic liver disease [OR:1.21(1.039-3.12)], chronic kidney disease [OR:2.30(1.277-6.098)]), prior carbapenem resistance [OR:1.369(1.037-3.66)], elevated CRP [OR:2.002(1.097-3.06)], vasopressor use within 48 h [OR:1.332(1.007-2.148)] and early septic shock [OR:1.99(1.071-5.649)]. Kaplan-Meier survival curves showed higher early mortality in CRKP patients, suggesting that they died even before a conventional culture report was available. Patients with CRKP bacteraemia showed significantly higher clinical severity and early mortality compared to those with CSKP infections. Rapid diagnostics, early appropriate empirical therapy in high-risk patients of CRKP and integrated stewardship strategies are critical for better outcomes. These findings offer actionable insights for risk stratification, diagnostic stewardship and timely intervention in high-burden settings.

VAVankadari Aditya
Vankadari Aditya
AKAkshatha Kotian
Akshatha Kotian
ASAnisha Sanil
Anisha Sanil
PTPoidal Mohammed-Ali Thaseena
Poidal Mohammed-Ali Thaseena
IKIndrani Karunasagar
Indrani Karunasagar
VDVK Deekshit
VK Deekshit
The gut forms a vital niche for the survival and replication of drug-resistant E. coli; however, the role of gut conditions on drug-resistant and sensitive E. coli is not clearly understood. The study aims to understand the effect of in vitro gut conditions on the spread of antibiotic resistance among E. coli and their ability to adapt to gut conditions. In this study, a multidrug-resistant (J51) and a sensitive (J254) E. coli isolate were exposed to a series of in vitro gut conditions and their growth pattern, virulence gene expression and invasion ability were studied. Further, the effect of antibiotic under in vitro gut conditions was also studied. Bile significantly affected the growth of the isolates, and the addition of iron chelator extended the lag phase of the sensitive isolate. Each in vitro gut condition had a differential effect on the expression of virulence genes in both the isolates. Further, the resistant isolate could adhere to and invade Caco2 cell lines better than the sensitive isolate. Most of the downregulated genes showed increased expression upon ciprofloxacin shock under in vitro gut conditions. The transcriptomics study revealed that exposure to bile, led to the downregulation of genes involved in different metabolic pathways. Further downregulation of metabolic pathways on ciprofloxacin shock was also observed. The downregulation of metabolic pathways could be a part of the global response played by the bacteria to adapt to harsh conditions. Reverting these fluctuated pathways could prove to be a novel strategy in combating AMR threat. Overall, bile, in high and low temperature conditions, showed a significant effect on modulating virulence gene expression on the antibiotic challenge. Thus, it is essential to consider the impact of gut conditions on gut pathogens, such as E. coli, before prescribing antimicrobial therapy during infection.

1 January 2022 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
SMShraddha Rani Modapathi
Shraddha Rani Modapathi
AKAnusha Karunasagar
Anusha Karunasagar
VAVankadari Aditya
Vankadari Aditya
VSVarsha Prakash Shetty
Varsha Prakash Shetty
AKAkshatha Kotian
Akshatha Kotian
VDVK Deekshit
VK Deekshit

10 October 2022 in Journal of Health and Allied Sciences NU
Verified
Journal Article
Open access
PDF file
LTLiz Therese Tony
Liz Therese Tony
AKAnusha Karunasagar
Anusha Karunasagar
VAVankadari Aditya
Vankadari Aditya
AKAkshatha Kotian
Akshatha Kotian
IKIndrani Karunasagar
Indrani Karunasagar
VDVK Deekshit
VK Deekshit
Background Emergence of fluoroquinolone resistance in gut pathogens is a cause of concern. Resistant to quinolone is mainly due to the point mutations at the quinolone-resistance determining regions (QRDR). The aim of the study was to develop polymerase chain reaction-restriction fragment length polymorphism assay (PCR-RFLP) to detect QRDR mutations in gyrA and gyrB regions in enteric pathogens. Methodology PCR-RFLP was done for gyrA 83 region using HinfI and for gyrB 447 using AcuI for fluoroquinolone resistant and susceptible gut pathogens. The products were also sequenced to confirm the presence of restriction sites. Results In this study, a PCR-RFLP technique was developed to detect gyrA 83 mutations in Salmonella typhi and Escherichia coli. A first of its kind PCR-RFLP was also developed to detect gyrB 447 mutation using a restriction enzyme AcuI. Restriction digestion of gyrA using HinfI resulted in three bands for resistant S. typhi isolates due to the presence of mutation at gyrA 83 and four bands were seen for sensitive S. typhi isolates, while two bands for resistant and three bands were seen in sensitive E. coli isolates. Similarly, restriction digestion of gyrB using AcuI resulted in no digestion for resistant S. typhi isolates and two bands for resistant E. coli isolates. This suggest that there is mutation at gyrB 447 region ofE. coli, while no mutation was found in S. typhi isolates. Conclusion The PCR-RFLP developed in the present study could successfully detect gyrA 83 and gyrB 447 mutations in fluoroquinolone-resistant S. typhi and E. coli. The technique can be efficiently used in epidemiological studies instead of a cost-intensive sequencing method to detect the status of multiple point mutations in gut pathogens.